Systematic review and meta-analysis of the adverse effects of thyroidectomy combined with central neck dissection as compared with thyroidectomy alone

Laryngoscope

Volumn 119, Issue 6, 2009, Pages 1135-1139

  Chisholm, Edward J ^a,c   Kulinskaya, Elena ^b   Tolley, Neil S ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Adverse effects; Central compartment neck dissection; Hypocalcemia; Thyroid carcinoma; Thyroidectomy; Vocal cord palsy

Indexed keywords

ADVERSE OUTCOME; ARTICLE; ATTRIBUTABLE RISK; CANCER PATIENT; CLINICAL TRIAL; HUMAN; HYPOCALCEMIA; INTERMETHOD COMPARISON; META ANALYSIS; MORBIDITY; NECK DISSECTION; PAPILLARY CARCINOMA; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURGICAL RISK; SYSTEMATIC REVIEW; THYROID CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; VOCAL CORD PARALYSIS; INJURY; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PARATHYROID GLAND; PATHOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; THYROID TUMOR;

CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; HUMANS; HYPOCALCEMIA; LYMPHATIC METASTASIS; NECK DISSECTION; PARATHYROID GLANDS; POSTOPERATIVE COMPLICATIONS; THYROID NEOPLASMS; THYROIDECTOMY; VOCAL CORD PARALYSIS;

EID: 66849115034     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.20236     Document Type: Article

References (20)

1. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006; 16:109-142.
2. Arturi F., Russo D., Giuffrida D., et al. Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 1997; 82:1638-1641.
3. Machens A., Hinze R., Thomusch O., Dralle H. Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 2002; 26:22-28.
4. Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone. Ann Surg 2007; 245:604-610.
5. Leboulleux S., Rubino C., Baudin E., et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005; 90:5723-5729.
6. Hughes CJ, Shaha AR, Shah JP, Loree TR. Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 1996; 18:127-132.
7. Toniato A., Boschin I., Casara D., Mazzarotto R., Rubello D., Pelizzo M. Papillary thyroid carcinoma: factors influencing recurrence and survival. Ann Surg Oncol 2008; 15: 1518-1522.
8. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748.
9. DSS Research. Researcher's Toolkit. Available at: http://www.dssresearch. com/toolkit/sscalc/size-p2.asp. Accessed September 2008.
10. Steinmuller T., Klupp J., Wenking S., Neuhaus P. Complications associated with different surgical approaches to differentiated thyroid carcinoma. Langenbecks Arch Surg 1999; 384:50-53.
11. Palestini N., Borasi A., Cestino L., Freddi M., Odasso C., Robecchi A. Is central neck dissection a safe procedure in the treatment of papillary thyroid cancer? Our experience. Langenbecks Arch Surg 2008; 393:693-698.
12. Henry JF, Gramatica L., Denizot A., Kvachenyuk A., Puccini M., Defechereux T. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 1998; 383:167-169.
13. Sywak M., Cornford L., Roach P., Stalberg P., Sidhu S., Delbridge L. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 2006; 140:1000-1005; discussion 1005-1007.
14. White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer. World J Surg 2007; 31:895-904.
15. White ML, Doherty GM. Level VI. Lymph node dissection for papillary thyroid cancer. Minerva Chir 2007; 62:383-393.
16. Jukkola A., Bloigu R., Ebeling T., Salmela P., Blanco G. Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 2004; 11:571-579.
17. Son YI, Jeong HS, Baek CH, et al. Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann Surg Oncol 2008; 15: 2020-2026.
18. Lundgren CI, Hall P., Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006; 106:524-531.
19. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U. S., 1985-1995. Cancer 1998; 83:2638-2648; comment 2434-2436.
20. Prophylactic central lymph node dissection in papillary thyroid microcarcinoma. Available at: http://clinicaltrials.gov/ct2/show/NCT00795782. Accessed December 2008.